High Tech Pharm Co. Ltd (106190.KQ) stock: key figures, P/E, revenue and dividend

Energy · Coal & Consumable Fuels · South Korea · ISIN KR7106190002

Price
8,620.00 KRW
Market cap
91.65 bn KRW
P/E (2025)
7.99
P/S (2025)
1.31
Dividend yield
1.74 %
Net margin
16.35 %
Return on equity (ROE)
8.78 %
Return on assets (ROA)
7.99 %

High Tech Pharm Co. Ltd financials

Fiscal year20242025
Revenue77.51 bn KRW70.18 bn KRW
Gross profit19.49 bn KRW16.94 bn KRW
Operating income15.56 bn KRW12.86 bn KRW
EBIT17.87 bn KRW14.01 bn KRW
Net income13.71 bn KRW11.48 bn KRW
Diluted EPS – continuing operations1,289.43 KRW1,079.24 KRW

Full history since 2014, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About High Tech Pharm Co. Ltd

High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.